Semi-Annual Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7714030

Concept 2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
Semi-annual statement of income
Statement of income
Net sales
82,017,000,000 JPY
-11,000,000 JPY
4,416,000,000 JPY
77,613,000,000 JPY
82,029,000,000 JPY
82,923,000,000 JPY
-11,000,000 JPY
78,496,000,000 JPY
4,438,000,000 JPY
82,935,000,000 JPY
Cost of sales
39,165,000,000 JPY
36,423,000,000 JPY
Ordinary profit (loss)
7,124,000,000 JPY
8,246,000,000 JPY
Gross profit (loss)
42,851,000,000 JPY
46,500,000,000 JPY
Extraordinary income
53,000,000 JPY
627,000,000 JPY
Selling, general and administrative expenses
36,057,000,000 JPY
38,694,000,000 JPY
Extraordinary losses
111,000,000 JPY
448,000,000 JPY
Selling, general and administrative expenses
Profit (loss) before income taxes
7,065,000,000 JPY
8,424,000,000 JPY
Operating profit (loss)
6,794,000,000 JPY
308,000,000 JPY
171,000,000 JPY
6,314,000,000 JPY
6,485,000,000 JPY
7,805,000,000 JPY
264,000,000 JPY
7,308,000,000 JPY
232,000,000 JPY
7,541,000,000 JPY
Income taxes - current
1,200,000,000 JPY
1,748,000,000 JPY
Non-operating income
634,000,000 JPY
550,000,000 JPY
Income taxes - deferred
753,000,000 JPY
556,000,000 JPY
Non-operating income
Interest income
26,000,000 JPY
19,000,000 JPY
Dividend income
382,000,000 JPY
370,000,000 JPY
Income taxes
1,953,000,000 JPY
2,304,000,000 JPY
Non-operating expenses
305,000,000 JPY
110,000,000 JPY
Profit (loss)
5,112,000,000 JPY
6,119,000,000 JPY
Non-operating expenses
Interest expenses
48,000,000 JPY
20,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
2,000,000 JPY
50,000,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.